Peptide Charge Derivatization as a Tool for Early Detection of Preeclampsia by Mass Spectrometry—A Comparison with the ELISA Test
Authors:
- Paulina GrocholskaPGPaulina Grocholska
- Andrzej KoniecznyAKAndrzej Konieczny
- Zuzanna KaźmierczakZKZuzanna Kaźmierczak
- Krystyna DąbrowskaKDKrystyna Dąbrowska
- Karolina Panek-LaszczyńskaKPKarolina Panek-Laszczyńska
- Marlena KłakMKMarlena Kłak
- Wojciech WitkiewiczWWWojciech Witkiewicz
- Zbigniew SzewczukZbigniew Szewczuk
- Remigiusz BąchorRBRemigiusz Bąchor
Open Access
- 24 November 2021
- Vol. 26 (23) , 7102
Abstract
Early detection of any preeclampsia biomarkers may lower the risk of mortality, both for a mother and a child. Our study focuses on techniques for preeclampsia biomarker identification by comparing the results of a method using liquid chromatography mass spectrometry in multiple reaction monitoring mode (LC-MS/MS) with those by the enzyme-linked immunosorbent assay (ELISA) test, as well as by comparing the obtained results with clinical data. In the proposed LC-MS/MS method a tryptic digest peptide charge derivatization strategy was used as a tool for sensitive detection of podocin, i.e., a previously discovered preeclampsia biomarker present in urine samples from pregnant women. Urine samples from pregnant women with diagnosed preeclampsia were collected at different stages of pregnancy and from healthy subjects, and then were analyzed by ELISA test and the proposed method with LC-MS/MS. Charge derivatization of the ε amino group of C-terminal lysine residues in tryptic digests by 2,4,6-triphenylpyrylium salt was performed to increase the ionization efficiency in the LC-MS/MS mode. Podocin was identified at the early stage of pregnancy, while its detection using an ELISA test was not possible. The protocol for urine sample preparation was optimized. Our results show that the proposed method by LC-MS/MS in combination with peptide charge derivatization, provides an ultrasensitive tool for diagnosis of preeclampsia, and provides earlier detection than a clinical diagnosis or ELISA test. The proposed solution may revolutionize medical diagnostics.Keywords
Funding Information
- Narodowe Centrum Nauki (UMO-2016/23/B/ST4/01036)
This publication has 39 references indexed in Scilit:
- Characterization of a short isoform of the kidney protein podocin in human kidneyBMC Nephrology, 2013
- Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicineEPMA Journal, 2013
- Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxinDiabetologia, 2012
- New perspectives on the renal slit diaphragm protein podocinLaboratory Investigation, 2011
- Correlation of Autophagy Type in Podocytes with Histopathological Diagnosis of IgA NephropathyPathobiology, 2009
- Acute and Transient Podocyte Loss and Proteinuria in PreeclampsiaNephron Clinical Practice, 2009
- Urinary podocyte excretion as a marker for preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2007
- The Major Podocyte Protein Nephrin Is Transcriptionally Activated by the Wilms’ Tumor Suppressor WT1Journal of the American Society of Nephrology, 2004
- In situ evaluation of podocin in normal and glomerular diseasesKidney International, 2003
- The Urinary Podocyte as a Marker for the Differential Diagnosis of Idiopathic Focal Glomerulosclerosis and Minimal-Change Nephrotic SyndromeAmerican Journal of Nephrology, 2000